Deeper Dive: Understanding Immunovant Inc (IMVT) Through its Various Ratios

Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.

The price of Immunovant Inc (NASDAQ: IMVT) closed at $19.52 in the last session, down -4.36% from day before closing price of $20.41. In other words, the price has decreased by -$4.36 from its previous closing price. On the day, 2.69 million shares were traded. IMVT stock price reached its highest trading level at $21.06 during the session, while it also had its lowest trading level at $19.09.

Ratios:

We take a closer look at IMVT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.04 and its Current Ratio is at 6.04. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Oppenheimer reiterated its Outperform rating for the stock on October 09, 2024, while the target price for the stock was revised from $47 to $53.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 22 ’25 when Stout Jay S sold 2,195 shares for $23.59 per share. The transaction valued at 51,780 led to the insider holds 139,991 shares of the business.

Geffner Michael sold 2,657 shares of IMVT for $62,679 on Jan 22 ’25. The Chief Medical Officer now owns 132,314 shares after completing the transaction at $23.59 per share. On Jan 15 ’25, another insider, Macias William L., who serves as the Chief Medical Officer of the company, sold 2,383 shares for $23.83 each. As a result, the insider received 56,782 and left with 359,408 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMVT now has a Market Capitalization of 3315686656 and an Enterprise Value of 2831228160.

Stock Price History:

The Beta on a monthly basis for IMVT is 0.67, which has changed by -0.44718307 over the last 52 weeks, in comparison to a change of 0.21659255 over the same period for the S&P500. Over the past 52 weeks, IMVT has reached a high of $39.55, while it has fallen to a 52-week low of $19.86. The 50-Day Moving Average of the stock is -21.48%, while the 200-Day Moving Average is calculated to be -29.97%.

Shares Statistics:

According to the various share statistics, IMVT traded on average about 1.09M shares per day over the past 3-months and 1576320 shares per day over the past 10 days. A total of 147.20M shares are outstanding, with a floating share count of 68.45M. Insiders hold about 59.70% of the company’s shares, while institutions hold 46.04% stake in the company. Shares short for IMVT as of 1736899200 were 12832296 with a Short Ratio of 11.74, compared to 1734048000 on 12631893. Therefore, it implies a Short% of Shares Outstanding of 12832296 and a Short% of Float of 14.760000000000002.

Most Popular